Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 335, Issue 2, 2010, Pages 389-400

  Kim, Yu Ri ^a   Eom, Ju In ^a   Kim, Soo Jeong ^a   Jeung, Hoi Kyung ^a   Cheong, June Won ^a   Kim, Jin Seok ^a   Min, Yoo Hong ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOHYDRAZIDE; ENZYME INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOPEROXIDASE; PARTHENOLIDE; PROTEIN BCL XL; PROTEIN MCL 1; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SURVIVIN; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; FLOW CYTOMETRY; GLUTATHIONE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED STRAINS; NEOPLASTIC STEM CELLS; PEROXIDASE; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SESQUITERPENES; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 78149254492     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.169367     Document Type: Article

References (38)

1. Baud V and Karin M (2009) Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 8:33-40.
2. Bork PM, Schmitz ML, Kuhnt M, Escher C, and Heinrich M (1997) Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-kappaB. FEBS Lett 402:85-90.
3. Brown AM, Edwards CM, Davey MR, Power JB, and Lowe KC (1997) Pharmacological activity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.): assessment by inhibition of human polymorphonuclear leukocyte chemiluminescence in-vitro. J Pharm Pharmacol 49:558-561.
4. Bryk R, Lima CD, Erdjument-Bromage H, Tempst P, and Nathan C (2002) Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein. Science 295:1073-1077.
5. Eiserich JP, Baldus S, Brennan ML, Ma W, Zhang C, Tousson A, Castro L, Lusis AJ, Nauseef WM, White CR, et al. (2002) Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296:2391-2394.
6. Graham SM, Jørgensen HG, Allan E, Pearson C, Alcorn MJ, Richmond L, and Holyoake TL (2002) Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 99:319-325.
7. Guan Y, Gerhard B, and Hogge DE (2003) Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood 101:3142-3149.
8. Guzman ML, Neering SJ, Upchurch D, Grimes B, Howard DS, Rizzieri DA, Luger SM, and Jordan CT (2001) Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 98:2301-2307.
9. Guzman ML, Rossi RM, Karnischky L, Li X, Peterson DR, Howard DS, and Jordan CT (2005) The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 105:4163-4169.
10. Hampton MB, Kettle AJ, and Winterbourn CC (1998) Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92:3007-3017.
11. Hayden MS and Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132:344-362.
12. Hehner SP, Hofmann TG, Dröge W, and Schmitz ML (1999) The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. J Immunol 163:5617-5623.
13. Holyoake T, Jiang X, Eaves C, and Eaves A (1999) Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 94:2056-2064.
14. Jordan CT and Guzman ML (2004) Mechanisms controlling pathogenesis and survival of leukemic stem cells. Oncogene 23:7178-7187.
15. Khoshnan A, Tindell C, Laux I, Bae D, Bennett B, and Nel AE (2000) The NF-kappaB cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes. J Immunol 165:1743-1754.
16. Kim JS, Eom JI, Cheong JW, Choi AJ, Lee JK, Yang WI, and Min YH (2007) Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia. Clin Cancer Res 13:1019-1028.
17. Klebanoff SJ (2005) Myeloperoxidase: friend and foe. J Leukoc Biol 77:598-625.
18. Knight DW (1995) Feverfew: chemistry and biological activity. Nat Prod Rep 12:271-276.
19. Kwok BH, Koh B, Ndubuisi MI, Elofsson M, and Crews CM (2001) The antiinflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase. Chem Biol 8:759-766.
20. Matsuo T, Kuriyama K, Miyazaki Y, Yoshida S, Tomonaga M, Emi N, Kobayashi T, Miyawaki S, Matsushima T, Shinagawa K, et al. (2003) The percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acute myeloid leukemia, even in the patients with normal karyotype. Leukemia 17:1538-1543.
21. Nakazato T, Sagawa M, Yamato K, Xian M, Yamamoto T, Suematsu M, Ikeda Y, and Kizaki M (2007) Myeloperoxidase is a key regulator of oxidative stress mediated apoptosis in myeloid leukemic cells. Clin Cancer Res 13:5436-5445.
22. Nakshatri H, Rice SE, and Bhat-Nakshatri P (2004) Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase. Oncogene 23:7330-7344.
23. Pajak B, Gajkowska B, and Orzechowski A (2008) Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells. Folia Histochem Cytobiol 46:129-135.
24. Pozarowski P, Halicka DH, and Darzynkiewicz Z (2003) Cell cycle effects and caspase-dependent and independent death of HL-60 and Jurkat cells treated with the inhibitor of NF-kappaB parthenolide. Cell Cycle 2:377-383.
25. Ross JJ, Arnason JT, and Birnboim HC (1999) Low concentrations of the feverfew component parthenolide inhibit in vitro growth of tumor lines in a cytostatic fashion. Planta Med 65:126-129.
26. Sawayama Y, Miyazaki Y, Ando K, Horio K, Tsutsumi C, Imanishi D, Tsushima H, Imaizumi Y, Hata T, Fukushima T, et al. (2008) Expression of myeloperoxidase enhances the chemosensitivity of leukemia cells through the generation of reactive oxygen species and the nitration of protein. Leukemia 22:956-964.
27. Sobota R, Szwed M, Kasza A, Bugno M, and Kordula T (2000) Parthenolide inhibits activation of signal transducers and activators of transcription (STATs) induced by cytokines of the IL-6 family. Biochem Biophys Res Commun 267:329-333.
28. Suvannasankha A, Crean CD, Shanmugam R, Farag SS, Abonour R, Boswell HS, and Nakshatri H (2008) Antimyeloma effects of a sesquiterpene lactone parthenolide. Clin Cancer Res 14:1814-1822.
29. Taguchi T, Takao T, Iwasaki Y, Nishiyama M, Asaba K, and Hashimoto K (2006) Suppressive effects of dehydroepiandrosterone and the nuclear factor-kappaB inhibitor parthenolide on corticotroph tumor cell growth and function in vitro and in vivo. J Endocrinol 188:321-331.
30. Takubo T, Kubota Y, Oguma S, Ueda T, Shibata H, Nakamura H, Masaoka T, Yoshitake J, and Ishigami S (1983) Classification of acute non-lymphocytic leukemia according to the distribution picture of peroxidase activity and cell size: correlation between the classification and therapeutic response. Blood Cells 9:501-514.
31. van Rhenen A, Feller N, Kelder A, Westra AH, Rombouts E, Zweegman S, van der Pol MA, Waisfisz Q, Ossenkoppele GJ, and Schuurhuis GJ (2005) High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival. Clin Cancer Res 11:6520-6527.
32. Wagner BA, Buettner GR, Oberley LW, Darby CJ, and Burns CP (2000) Myeloperoxidase is involved in H2O2-induced apoptosis of HL-60 human leukemia cells. J Biol Chem 275:22461-22469.
33. Wang W, Adachi M, Kawamura R, Sakamoto H, Hayashi T, Ishida T, Imai K, and Shinomura Y (2006) Parthenolide-induced apoptosis in multiple myeloma cells involves reactive oxygen species generation and cell sensitivity depends on catalase activity. Apoptosis 11:2225-2235.
34. Wen J, You KR, Lee SY, Song CH, and Kim DG (2002) Oxidative stress-mediated apoptosis. The anticancer effect of the sesquiterpene lactone parthenolide. J Biol Chem 277:38954-38964.
35. Wiedhopf RM, Young M, Bianchi E, and Cole JR (1973) Tumor inhibitory agent from Magnolia grandiflora (Magnoliaceae). I. Parthenolide. J Pharm Sci 62:345.
36. Woynarowski JM and Konopa J (1981) Inhibition of DNA biosynthesis in HeLa cells by cytotoxic and antitumor sesquiterpene lactones. Mol Pharmacol 19:97-102.
37. Zhang S, Lin ZN, Yang CF, Shi X, Ong CN, and Shen HM (2004a) Suppressed NF-kappaB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-alpha-induced apoptosis in human cancer cells. Carcinogenesis 25:2191-2199.
38. Zhang S, Ong CN, and Shen HM (2004b) Critical roles of intracellular thiols and calcium in parthenolide-induced apoptosis in human colorectal cancer cells. Cancer Lett 208:143-153.